SEER

Seer, Inc. (NASDAQ:SEER) is a life sciences company founded in 2017 and headquartered in Redwood City, California. The company went public in December 2020 and specializes in developing and commercializing advanced proteomics technology to help researchers decode the complexities of the human proteome. Seer has positioned itself as a pioneer in deep, unbiased proteomics analysis at scale, serving over 135 customers across 20 countries through its flagship Proteograph Product Suite.